Company Brings On Former CIO/CTO From Regional Health Plans PALO ALTO, Calif., Sept. 18, 2025 /PRNewswire/ -- Penguin Ai, a healthcare...
CARSON, Calif., Sept. 18, 2025 /PRNewswire/ -- For more than 40 years, the International Dermal Institute (IDI) has set the gold...
JEFFERSONVILLE, Ind. and MORRISVILLE, N.C., Sept. 18, 2025 /PRNewswire/ -- Valeris, a fully integrated life sciences commercialization partner that provides...
AUSTIN, Texas and TOKYO, Sept. 18, 2025 /PRNewswire/ -- According to DataM Intelligence, the global AI in remote patient monitoring market...
Kevin R. Hanz, MD: Dallas' Choice for Best in Cosmetic Surgery, Liposuction, and Breast Augmentation DALLAS, TX / ACCESS Newswire...
Criteria updates include new AI program, cyber resilience recommendations WASHINGTON, DC / ACCESS Newswire / September 18, 2025 / DirectTrust®,...
MESA, ARIZONA / ACCESS Newswire / September 18, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE), a leader in AI-powered...
DENVER, CO AND MAHWAH, NJ / ACCESS Newswire / September 18, 2025 / ForCast Orthopedics, Inc. and KORU Medical Systems,...
After treating 50,000+ patients abroad, the Norwegian startup closes $4.5M seed round, opens U.S. headquarters, and launches Acne Care app....
Rethink Impact leads investment round as company targets expansion to 30+ states by end of 2026 WASHINGTON, DC / ACCESS...
New in vitro results show Telomir-1 adds KDM5 family inhibition to its previously reported KDM2/KDM6 and DNA methylation activity, potentially...
The Company plans to use the proceeds to accelerate the development of Teverelix, a next generation GnRH Antagonist, as a...
TAMPA, FLORIDA / ACCESS Newswire / September 18, 2025 / The America's Best Plastic Surgeons in America 2025 list from...
Intellectual property portfolio now includes 228 Patents and 153 Trademarks providing robust protection for the Company's product platforms in the...
Noom launches microhabits free tier to make healthier living easier and more sustainable for everyone Noom is launching a national...
First combination therapy to report 29.5 months of Median Overall Survival (mOS); Standard of care Keytruda® (pembrolizumab) alone (10.8 months)...
New Taipei City, Taiwan, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company”, “Jyong Biotech”), a...
NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement...
Dr. Duncan's appointment to this prestigious role recognizes his extraordinary contributions to the actuarial profession and healthcare innovation over three...
Donnelly brings more than 25 years of biopharmaceutical expertise in CMC and regulatory operationsSEATTLE and VANCOUVER, British Columbia, Sept. 18,...